Yüklüyor......

Identification of apolipoprotein A-I in BALF as a biomarker of sarcoidosis

Background: Sarcoidosis goes into remission in two-thirds of patients with sarcoidosis, but about 20 % of patients develop pulmonary fibrosis. The mechanisms of pulmonary fibrosis in sarcoidosis and differences in pathogenesis between clinical stages are still unclear. Objectives: The aim of this st...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Sarcoidosis Vasc Diffuse Lung Dis
Asıl Yazarlar: Nukui, Yoshihisa, Miyazaki, Yasunari, Suhara, Kozo, Okamoto, Tsukasa, Furusawa, Haruhiko, Inase, Naohiko
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Mattioli 1885 2018
Konular:
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7170057/
https://ncbi.nlm.nih.gov/pubmed/32476874
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.36141/svdld.v35i1.5834
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!